Trinity Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Net Income	-24.02	-41.01	0.88	-6.39	-28.91	-22.09	-40.27	-100.63	21.8	17.21	Upgrade
Depreciation & Amortization	-	2.33	2.74	3.08	4.89	4.12	5.2	6.13	5.64	4.5	Upgrade
Share-Based Compensation	-	1.76	1.1	0.79	0.76	1.37	0.93	1.41	1.55	1.5	Upgrade
Other Operating Activities	24.02	36.01	6.91	27.19	28.68	23.83	43.39	103.31	-15.83	-7.15	Upgrade
Operating Cash Flow	-	-0.91	11.63	24.67	5.42	7.23	9.25	10.23	13.16	16.06	Upgrade
Operating Cash Flow Growth	-	-	-52.86%	355.44%	-25.07%	-21.85%	-9.56%	-22.26%	-18.08%	71.63%	Upgrade
Capital Expenditures	-	-5.98	-8.69	-10.2	-11.85	-17.39	-15.07	-20.76	-26.59	-27.76	Upgrade
Other Investing Activities	-	-	-	-	-	-	-1.11	-1.11	-1.11	-	Upgrade
Investing Cash Flow	-	-5.98	-8.69	-10.2	-11.85	-17.39	-16.18	-21.88	-27.7	-27.76	Upgrade
Dividends Paid	-	0	0	0	0	0	0	0	-5.1	-5.03	Upgrade
Share Issuance / Repurchase	-	25.4	0	0	0	-0.43	-7.8	-8.47	2.94	3.64	Upgrade
Debt Issued / Paid	-	-37.52	-6.02	-2.72	-7.53	-16.92	-4.9	-4.88	114.15	0	Upgrade
Other Financing Activities	-	-0.2	-	-	-	0.48	0.05	-0.01	-4.48	-0.04	Upgrade
Financing Cash Flow	-	-12.32	-6.02	-2.72	-7.53	-16.87	-12.64	-13.36	107.52	-1.43	Upgrade
Exchange Rate Effect	-	-0.11	0.06	0.09	0.09	-0.3	0.07	0.16	-0.13	-0.09	Upgrade
Net Cash Flow	-	-19.22	-1.47	10.84	-13.97	-27.03	-19.57	-25	92.98	-13.12	Upgrade
Free Cash Flow	-	-6.89	2.94	14.47	-6.44	-10.16	-5.82	-10.54	-13.43	-11.7	Upgrade
Free Cash Flow Growth	-	-	-79.70%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-	-11.01%	3.16%	14.19%	-7.12%	-10.47%	-5.87%	-10.58%	-13.40%	-11.15%	Upgrade
Free Cash Flow Per Share	-	-1.65	0.70	3.46	-1.34	-2.11	-1.21	-2.20	-2.85	-2.54	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).